DBV Technologies (DBVT) Tax Rate (2020 - 2026)

DBV Technologies (DBVT) posted Tax Rate of 0.4% for Q2 2026, up 5.58% sequentially from 0.42% in Q1 2026, and down 16.0% YoY from 0.47% in Q2 2025.

DBV Technologies (DBVT) Tax Rate (2020 - 2026) Analysis & Trends

DBV Technologies has reported Tax Rate for 7 years, with the latest figure at 0.4% in Q2 2026.

Quarterly Tax Rate fell 16.0% year-over-year to 0.4% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.44% (down 35.0% YoY) and the FY2025 annual result came in at 0.34%, down 29.0% from the prior year.
Tax Rate grew to 0.4% in Q2 2026 per DBVT's latest filing, from 0.42% in the prior quarter.
Over five years, Tax Rate peaked at 0.05% in Q4 2023 and troughed at 0.84% in Q4 2025.
A 5-year average of 0.26% and a median of 0.21% in 2024 frame the typical range for Tax Rate.
The sharpest annual moves came in 2022 and 2025: Tax Rate rose 21 bps in 2022, then plunged 81 bps in 2025.
Over 5 years, Tax Rate stood at 0.04% in 2022, then advanced by 24 bps to 0.05% in 2023, then plunged by 157 bps to 0.03% in 2024, then sank by 2665 bps to 0.84% in 2025, then soared by 53 bps to 0.4% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 0.4%, 0.42%, and 0.84% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	DBV Technologies	6.08 Bn	5.90 Bn	-	-0.40%

Download Data